When it comes to developing capacity for tackling cancer, all too often the best intentions founder because key players are not engaged, costings are not done, sustainable funding is not secured, visiting experts dispense their [more]
The need to give greater weight to patients’ own assessments of treatment impacts is increasingly accepted in principle. Putting it into practice will require a lot of hard work, developing tools that work for specific [more]
‘Survivorship’ is a rapidly growing field of research, as more cancer patients live longer, and require different types of support to get their lives back on track. Typically such research has been disconnected from clinical [more]
A professor of haematology, specialising in bone marrow transplants and leukaemia, with a career that has spanned clinical practice, research, policy making and now political office – Agnès Buzyn has an unrivalled breadth of experience [more]
Some scholars recently coined the expression “Medical Misinformation Mess” to describe current clinical medicine as a realm in which it is very difficult to evaluate both reliability and practical meaning of research studies. A realm [more]